Nasser E Mikhail

Summary

Affiliation: Olive View-UCLA Medical Center
Country: USA

Publications

  1. ncbi request reprint The metabolic syndrome: insulin resistance
    Nasser Mikhail
    Division of Endocrinology, Department of Medicine, Olive UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Curr Hypertens Rep 11:156-8. 2009
  2. doi request reprint Management of hyperglycemia in hospitalized noncritical patients
    Nasser Mikhail
    Department of Medicine, Endocrinology Division, Olive View University of California Los Angeles Medical Center, Sylmar, CA 91342, USA
    South Med J 106:238-46. 2013
  3. ncbi request reprint Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, CA 91342, USA
    Curr Drug Saf 6:304-9. 2011
  4. ncbi request reprint Exenatide: a novel approach for treatment of type 2 diabetes
    Nasser Mikhail
    Endocrinology Division, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    South Med J 99:1271-9. 2006
  5. ncbi request reprint Does testosterone have a role in erectile function?
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, Sylmar, Calif 91342, USA
    Am J Med 119:373-82. 2006
  6. ncbi request reprint Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Expert Opin Investig Drugs 17:845-53. 2008
  7. ncbi request reprint LIPID abnormalities in patients infected with human immunodeficiency virus
    Nasser E Mikhail
    Endocrinology Division, Olive View University of California Los Angeles Medical Center, Sylmar, California 91342, USA
    Endocr Pract 14:492-500. 2008
  8. pmc Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential
    Nasser Mikhail
    Endocrinology Division, Olive View UCLA Medical Center, David Geffen School of Medicine, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Vasc Health Risk Manag 4:1221-7. 2008
  9. ncbi request reprint Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin
    Nasser Mikhail
    Department of Medicine, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Curr Drug Saf 4:121-2. 2009
  10. ncbi request reprint Management of erectile dysfunction by the primary care physician
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, Sylmar, CA 91342 1495, USA
    Cleve Clin J Med 72:293-4, 296-7, 301-5 passim. 2005

Detail Information

Publications31

  1. ncbi request reprint The metabolic syndrome: insulin resistance
    Nasser Mikhail
    Division of Endocrinology, Department of Medicine, Olive UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Curr Hypertens Rep 11:156-8. 2009
    ..This review provides an update on the relationship between insulin resistance and main components of the metabolic syndrome: hyperglycemia, dyslipidemia, hypertension, and obesity...
  2. doi request reprint Management of hyperglycemia in hospitalized noncritical patients
    Nasser Mikhail
    Department of Medicine, Endocrinology Division, Olive View University of California Los Angeles Medical Center, Sylmar, CA 91342, USA
    South Med J 106:238-46. 2013
    ..Further studies are required to determine the ideal glycemic goals and insulin treatment strategies for control of hyperglycemia in hospitalized noncritically ill patients...
  3. ncbi request reprint Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, CA 91342, USA
    Curr Drug Saf 6:304-9. 2011
    ..Overall, although short-term safety of DPP-4 inhibitors is reassuring, their safety needs to be established by long-term clinical trials and close surveillance during the postmarketing period...
  4. ncbi request reprint Exenatide: a novel approach for treatment of type 2 diabetes
    Nasser Mikhail
    Endocrinology Division, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    South Med J 99:1271-9. 2006
    ..The introduction of GLP-1-based antidiabetic drugs is a novel and promising strategy to treat diabetes...
  5. ncbi request reprint Does testosterone have a role in erectile function?
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, Sylmar, Calif 91342, USA
    Am J Med 119:373-82. 2006
    ..The main objectives of this review are to clarify the role of testosterone in erectile function and evaluate its therapeutic value in men with erectile dysfunction (ED)...
  6. ncbi request reprint Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Expert Opin Investig Drugs 17:845-53. 2008
    ..Sitagliptin and vildagliptin can also be used as monotherapy in patients with type 2 diabetes uncontrolled by diet...
  7. ncbi request reprint LIPID abnormalities in patients infected with human immunodeficiency virus
    Nasser E Mikhail
    Endocrinology Division, Olive View University of California Los Angeles Medical Center, Sylmar, California 91342, USA
    Endocr Pract 14:492-500. 2008
    ..To review the types, mechanisms, clinical implications, and management of lipid abnormalities associated with human immunodeficiency virus (HIV) infection and its treatment...
  8. pmc Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential
    Nasser Mikhail
    Endocrinology Division, Olive View UCLA Medical Center, David Geffen School of Medicine, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Vasc Health Risk Manag 4:1221-7. 2008
    ..The combination of sitagliptpin or vildagliptin with pioglitazone can be a useful therapeutic approach in patients with type 2 diabetes who cannot tolerate metformin or a sulfonylurea...
  9. ncbi request reprint Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin
    Nasser Mikhail
    Department of Medicine, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Curr Drug Saf 4:121-2. 2009
    ..His symptoms resolved within 10 days after the discontinuation of pravastatin and antiretroviral therapy. To our knowledge, this is the first case of rhabdomyolysis possibly caused by pravastatin in an HIV-infected patient...
  10. ncbi request reprint Management of erectile dysfunction by the primary care physician
    Nasser Mikhail
    Endocrinology Division, Department of Medicine, Olive View UCLA Medical Center, Sylmar, CA 91342 1495, USA
    Cleve Clin J Med 72:293-4, 296-7, 301-5 passim. 2005
    ..The following review provides a practical approach for the management of erectile dysfunction in primary care...
  11. ncbi request reprint Is exenatide a useful addition to diabetes therapy?
    Nasser E Mikhail
    Endocrinology Division, Department of Medicine, Olive View University of California at Los Angeles UCLA Medical Center, UCLA School of Medicine, Sylmar, California, USA
    Endocr Pract 12:307-14. 2006
    ..To present an evidence-based evaluation of the antidiabetic drug exenatide...
  12. ncbi request reprint Insulin resistance in HIV-related lipodystrophy
    Nasser Mikhail
    Endocrinology Division, Olive View UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA
    Curr Hypertens Rep 5:117-21. 2003
    ..Further investigations are urgently needed to define the mechanisms and cardiovascular consequences of insulin resistance in HIV-related LD, and to find an effective treatment for this complex syndrome...
  13. doi request reprint Is liraglutide a useful addition to diabetes therapy?
    Nasser E Mikhail
    Department of Medicine, University of California Medical Center, Sylmar, CA, USA
    Endocr Pract 16:1028-37. 2010
    ..To evaluate liraglutide as an antidiabetic agent...
  14. ncbi request reprint Gliptins
    Nasser Mikhail
    Lancet 369:269. 2007
  15. ncbi request reprint The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients: response to Poulsen et al
    Nasser Mikhail
    Diabetes Care 27:1846-7; author reply 1847-8. 2004
  16. ncbi request reprint Insulin combination therapy in type 2 diabetes mellitus
    Nasser Mikhail
    Ann Intern Med 140:666-7; author reply 667. 2004
  17. ncbi request reprint An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea: response to Barnett et al
    Nasser Mikhail
    Diabetes Care 29:2332-3; author reply 2333. 2006
  18. doi request reprint Cardiovascular safety of low-dose rosiglitazone
    Nasser Mikhail
    Arch Intern Med 168:109. 2008
  19. ncbi request reprint Why should we avoid the use of rosiglitazone?
    Nasser Mikhail
    South Med J 101:329-31. 2008
  20. ncbi request reprint Primary care-based disease management for patients with diabetes
    Nasser Mikhail
    Am J Med 118:1444-5; author reply 1445-6. 2005
  21. ncbi request reprint The use of niacin in diabetes mellitus
    Nasser Mikhail
    Arch Intern Med 163:369-70; author reply 370. 2003
  22. ncbi request reprint Low-dose hormone replacement therapy for hot flashes
    Nasser Mikhail
    Mayo Clin Proc 78:379; author reply 379. 2003
  23. ncbi request reprint Hypogonadism and osteoporosis in men
    Nasser Mikhail
    Arch Intern Med 163:1237; author reply 1237-8. 2003
  24. ncbi request reprint The use of statins in conjunction with protease inhibitors and in renal insufficiency
    Nasser Mikhail
    Arch Intern Med 163:1615-6; author reply 1616. 2003
  25. ncbi request reprint Antihyperglycemic therapy for patients with renal failure
    Nasser Mikhail
    JAMA 290:1026-7; author reply 1027. 2003
  26. ncbi request reprint Comments on the MRC/BHF Heart Protection Study
    Nasser Mikhail
    Lancet 362:744; author reply 744-5. 2003
  27. ncbi request reprint The JNC-7 guidelines and the optimal target for systolic blood pressure
    Nasser Mikhail
    Hypertension 43:e31; author reply e31. 2004
  28. ncbi request reprint Efficacy and safety of sildenafil in patients with congestive heart failure
    Nasser Mikhail
    Arch Intern Med 164:2067-8. 2004
  29. ncbi request reprint Rosiglitazone for treatment of HIV lipodystrophy
    Nasser Mikhail
    Ann Intern Med 141:739; author reply 739-40. 2004
  30. ncbi request reprint Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin
    Nasser Mikhail
    Am J Emerg Med 23:415-7. 2005
  31. ncbi request reprint Drug therapy for patients with type 2 diabetes
    Nasser Mikhail
    JAMA 287:1645-6; author reply 1646. 2002